Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Outcome for Submission Of Outcome Of Board Meeting Held On 27Th July, 2022 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Submission of Outcome of Board Meeting held on 27-07-2022 wherein Board of Directors has considered and approved, inter alia: 1. Unaudited Financial Results along with Limited Review Report thereon as received from the Statutory Auditors of the Company for the quarter 30-06-2022 as prepared in accordance with Reg. 33 of the SEBI (LODR) Regulations, 2015. 2. re-appointment of Mr. Devkinandan Sharma as an Non-Executive Independent Director; subject to the approval for shareholders in this ensuing AGM;for the 2nd consecutive term of 5 years; 3. re-appointment of M/s. Saremal & Company (FRN:109281W), Chartered Accountant, Ahmedabad; subject to the approval for shareholders in this ensuing Annual General Meeting; for 2nd consecutive term of 1 year; 4. the date, time and mode of convening 28thAGM of the Company, to be held on Tuesday, 23rd August, 2022 at 3.00 P.M. through Video Conferencing (VC)/Other Audio Visual means(OAVM) alongwith approval of Notice of AGM in that regard.
27-07-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Along With The Limited Review Report Thereon As Per Regulation 33 Of SEBI (LODR) Regulations, 2015 For Quarter Ended 30Th June, 2022.

 Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2022 ,inter alia, to consider and approve Unaudited Financial Results along with the Limited Review Report thereon as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for quarter ended 30th June, 2022.
21-07-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Submission of confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2022 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company.
19-07-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Submission of disclosure on Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Half Year ended from 01st October, 2021 to 31st March, 2022
09-06-2022
Bigul

Annual report for Kashyap Tele-Medicines Ltd. for FY-2022
28-05-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Submission Of Audited Financial Results, Statement Of Assets And Liabilities, Cash Flow Statement And Auditor'S Report For The Quarter And Financial Year Ended 31St March, 2022 Pursuant To Regulation 33 Of SEBI (LODR) Regulations, 2015 And An Unmodified Opinion Thereon.

 Submission of the Audited Financial Results, Statement of Assets and Liabilities & Cash Flow Statement of the Company for the quarter and financial year ended 31st March, 2022 as prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015 (IND-AS) along with Audit Report thereon which were duly reviewed & recommended by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on 27th May, 2022.
27-05-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Outcome for Submission Of Outcome Of Board Meeting Held On 27Th May, 2022 As Per Regulation 30 Of SEBI (LODR) Regulations, 2015.

 As per intimation given for meeting of the Board of Directors, we are pleased to inform that in meeting duly convened on 27th May, 2022 Board of Directors has considered and approved, inter alia: 1. Audited Financial Results, Statement of Assets and Liabilities & Cash Flow Statement of the Company for the Quarter and Financial Year ended on 31st March, 2022; prepared in accordance with Regulation 33 of the SEBI (LODR) Regulations, 2015 and Schedule III of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015 (IND-AS); alongwith the Independent Auditor''s Report thereon as received from the Statutory Auditors of the Company [M/s. Saremal & Company, (FRN: 109281W), Practicing Chartered Accountants, Ahmedabad] and the said Auditors have expressed an Unmodified Opinion thereon; the copies of which are enclosed herewith 2. All other businesses as per agenda circulated.
27-05-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results, Statement Of Assets And Liabilities, Cash Flow Statement And Audit Report Thereon.

 Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve the Audited Financial Results, Statement of Assets and Liabilities, Cash Flow Statement and Audit Report thereon as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for quarter and financial year ended 31st March, 2022 and to transact all such other businesses as per the agenda items of the Meeting
19-05-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKashyap Tele-Medicines Ltd 2CINL29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: CS PARITOSH TRIVEDI Designation: Company Secretary EmailId: investor.relations@kashyaptele-medicines.com Name of the Chief Financial Officer: Raghav Agrawal Designation: Director and Chief Financial Officer EmailId: investor.relations@kashyaptele-medicines.com Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2022
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Intimation of non-applicability of Annual Secretarial Compliance Report for the year ended 31st March, 2022 under regulation 24A of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 and Circular No: CIR/CFD/CMD1/27/2019 Dated 8th February, 2019.
26-04-2022
Next Page
Close

Let's Open Free Demat Account